Featured by Healthinvestor UK: The opportunities in the UK healthcare sector

Featured by Healthinvestor UK: The opportunities in the UK healthcare sector

April 28, 2025
April 28, 2025

Share

UK independent healthcare is gaining ground as the NHS struggles with several key challenges, including record wait times, staff shortages, and draining capital. In an in-depth discussion with HealthInvestor UK, Managing Director Adam Thorpe highlights how providers who capitalize on tightening government budgets, while continually delivering quality care in high-need areas, are poised to succeed—especially if they strike the right balance between public service and profitable private offerings.


Learn why Adam believes UK healthcare is entering a pivotal moment, what challenges he feels remain for independent providers, and his observations on how private sector involvement is shaping the future of care delivery.

Adam Thorpe
Adam Thorpe

“The UK has always felt very proud of the NHS, but attitudes are shifting, and the NHS needs to evolve. It makes sense for patients to get treatment in the independent sector if they are satisfied with the quality and CQC rating of the provider and it helps reduce waiting times and improve outcomes.


“There is more NHS funded volume going into the independent sector than before, but patients are also increasingly acting as consumers and getting treatment funded by private medical insurance or just paying themselves. This is a notable trend compared with 5-10 years ago.”


-Adam Thorpe, Managing Director, Healthcare

Read the full article here Read the full article here
Adam Thorpe

“The UK has always felt very proud of the NHS, but attitudes are shifting, and the NHS needs to evolve. It makes sense for patients to get treatment in the independent sector if they are satisfied with the quality and CQC rating of the provider and it helps reduce waiting times and improve outcomes.


“There is more NHS funded volume going into the independent sector than before, but patients are also increasingly acting as consumers and getting treatment funded by private medical insurance or just paying themselves. This is a notable trend compared with 5-10 years ago.”


-Adam Thorpe, Managing Director, Healthcare

Read the full article here

Read More

Will Barden Named Among The Consulting Report’s Top 25 Strategy Leaders of 2025
By Will Barden December 11, 2025
Will Barden, Partner, has been named among "The Consulting Report's" Top 25 Strategy Leaders of 2025. Click here to read more about the award.
Investing in Pharma Technology: A Healthcare Breakfast Discussion
By Rob Larson & Jordan Abrams December 8, 2025
In partnership with Raymond James and Farragut Square Group, Grant Thornton Stax recently hosted a breakfast event to share our investment analysis of the Pharma Technology market.
Miriam El-Baz & Connor Novy Honored as Consulting Magazine Women Leaders
December 2, 2025
Miriam El-Baz and Connor Novy were recognized at the Consulting Magazine Women Leaders awards to highlight the outstanding contributions made by women in consulting. Read more.
Featured in Financier Worldwide—Accelerating value in PE carve-outs: strategy and execution
By Phil Dunne & Peter Rodrigues-Renon November 11, 2025
Financier Worldwide discusses strategy & execution for accelerating value in carve-outs with Phil Dunne and Peter Rodrigues-Renon at Stax, including Gerard Nichol at Grant Thornton. Read more.
Key Considerations for Investors Exploring the Automotive Retail Tech Value Chain
By Sameer Tejani & Max Massaro November 6, 2025
Investment focus in automotive technology continues to broaden beyond OEMs to the core service ecosystem. Read what Sameer Tejani and Max Massaro see in the market.
Grant Thornton Stax Provides Sell-Side Support to SteelEye on its Merger With FundApps​
November 3, 2025
Grant Thornton Stax supported SteelEye, a leading trade and communications surveillance and data analytics platform, on its recent merger with FundApps. Read about the deal here.
Show More